New Zealand markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
495.73-0.23 (-0.05%)
At close: 04:00PM EDT
495.40 -0.33 (-0.07%)
After hours: 07:35PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close495.96
Open497.72
Bid495.38 x 100
Ask495.91 x 200
Day's range490.00 - 500.15
52-week range372.50 - 583.39
Volume1,125,318
Avg. volume502,033
Market cap40.941B
Beta (5Y monthly)1.33
PE ratio (TTM)48.08
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

    IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go workflow of the Catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes. The Catalyst Pancreatic Lipase Test will be available in the U.S. and Ca

  • Business Wire

    IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day

    WESTBROOK, Maine, May 14, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 10:55 am – 11:25 am (EDT).

  • Business Wire

    IDEXX Laboratories Announces First Quarter Results

    WESTBROOK, Maine, May 01, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.